Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes: response to Yamamoto et al.
Yamagishi
Sho-ichi
S
D015519:Bone Density / Q000502:physiology*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications* / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008297:Male; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic / Q000097:blood*; D012307:Risk Factors; D016103:Spinal Fractures / Q000097:blood* / Q000453:epidemiology* / Q000209:etiology
D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic